1. Pain Management and the Opioid Epidemic: Balancing Societal and Individual Benefits and Risks of Prescription Opioid Use,2017
2. Medicare formulary coverage and restrictions for opioid potentiators from 2013 to 2017;Vijay;J Gen Intern Med,2019
3. FDA requires strong warnings for opioid analgesics, prescription opioid cough products, and benzodiazepine labeling related to serious risks and death from combined use;U.S. Food & Drug Administration,2016
4. Reduce risk of opioid overdose deaths by avoiding and reducing co-prescribing benzodiazepines,2019
5. Opioid and benzodiazepine coprescribing in the United States before and after U.S. Food and Drug Administration boxed warning;Zhang;JAMA Psychiatry,2019